[Pharmacotherapy and analysis of the course of pregnancy and perinatal outcomes in women with hypertensive disease].
Striuk
R I
RI
Bukhonkina
Iu M
IuM
Sokova
E A
EA
Nemirovskiĭ
V B
VB
Kosmacheva
A V
AV
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D021041:Placental Circulation / Q000187:drug effects; D011247:Pregnancy; D011256:Pregnancy Outcome
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers